AOD-9604: The Fat Loss Fragment Researchers Broke Off from HGH

AOD-9604 has one of the more interesting origin stories in peptide research. It was not developed from scratch — it was extracted from human growth hormone itself. Researchers wanted to find out which part of the HGH molecule was responsible for its fat-burning effects, isolate it, and study it without everything else that comes with full HGH. What they found has made AOD-9604 one of the more focused tools in metabolic peptide research.

What Is AOD-9604?

AOD-9604 is a modified fragment of the C-terminal region of human growth hormone — specifically amino acids 176-191, with an additional tyrosine residue added to stabilize the peptide. The name AOD stands for “anti-obesity drug,” reflecting its original development purpose.

The full HGH molecule does many things: it promotes cell growth, stimulates IGF-1 production, affects carbohydrate metabolism, and influences fat metabolism. AOD-9604 was created specifically to isolate the fat metabolism piece. Research suggests it retains HGH’s lipolytic (fat-breaking) properties without the growth-promoting or glucose-disrupting effects that come with full HGH.

What Does Research Show About Lipolysis and Fat Metabolism?

• Lipolysis stimulation: Studies in animal models show that AOD-9604 stimulates the breakdown of fat (lipolysis) in adipose tissue. It appears to do this through the same receptor pathway as the fat-metabolism portion of HGH.
• Inhibition of lipogenesis: Research suggests AOD-9604 may also inhibit lipogenesis — the process by which the body converts carbohydrates into fat. This dual action (more fat burning, less fat storage) is a central focus of metabolic research with this compound.
• Obese rodent models: Studies in diet-induced obese mice have shown significant reductions in body fat in AOD-9604-treated subjects compared to controls, without the negative metabolic effects sometimes observed with full HGH.
• No effect on blood glucose or IGF-1: Unlike full HGH, studies show AOD-9604 does not significantly raise IGF-1 levels or disrupt glucose metabolism — a finding that has made it useful for researchers wanting to study fat metabolism in isolation.

Why Do Researchers Study It Separately From Full HGH?

Full HGH is a complex molecule with a wide range of effects across multiple systems. For researchers specifically studying fat metabolism, the broad activity of full HGH introduces too many confounding variables. AOD-9604 allows researchers to study lipolytic mechanisms with much greater specificity.

Think of it as a research tool that lets scientists ask a narrower question: what happens to fat metabolism when you activate only this specific part of the HGH pathway? That kind of precision is valuable in metabolic research design.

Metabolic Research Applications

AOD-9604 reached Phase II and Phase III clinical trials in humans for obesity treatment — giving it one of the more substantial clinical research histories among peptides in this category. While it did not receive FDA approval for obesity treatment, the clinical data generated during those trials remains a valuable resource for metabolic researchers. Areas of ongoing study include fat distribution in aging, metabolic syndrome, and the interplay between lipolysis and energy expenditure.

All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use.

Source research-grade AOD-9604 at peptivigor.com — see AOD-9604 5mg. Use code LABVIP1 at checkout to get 15% off your order.